NCT01796626View on ClinicalTrials.gov

Clinical Evaluation of M22 ResurFX 1565nm Module

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
WrinklesStriae
Interventions
DEVICE

M22 ResurFX module

The system delivers pulsed near Infra-Red (NIR) laser light with a nominal wavelength of 1565 nm and has a unique treatment handpiece with epidermal cooling. The clinician is able to control the settings of energy, µBeams density, scan size, and shape option from the user interface (LCD GUI) display on the main M22 console.

Trial Locations (2)

10028

New York Laser & Skin Care, New York

Unknown

DCLA, San Diego

All Listed Sponsors
lead

Lumenis Be Ltd.

INDUSTRY

NCT01796626 - Clinical Evaluation of M22 ResurFX 1565nm Module | Biotech Hunter | Biotech Hunter